Label: METAXALONE tablet

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated February 25, 2021

If you are a consumer or patient please visit this version.

  • INDICATIONS & USAGE

    Metaxalone tablets are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomforts associated with acute, painful musculoskeletal conditions. The mode of action of this drug has not been clearly identified, but may be related to its sedative properties. Metaxalone does not directly relax tense skeletal muscles in man.

  • PRINCIPAL DISPLAY PANEL

    Metaxalone - Bottle

  • INGREDIENTS AND APPEARANCE
    METAXALONE 
    metaxalone tablet
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:80175-0472(NDC:64980-472)
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    METAXALONE (UNII: 1NMA9J598Y) (METAXALONE - UNII:1NMA9J598Y) METAXALONE800 mg
    Product Characteristics
    ColorpinkScore2 pieces
    ShapeOVALSize19mm
    FlavorImprint Code AC127
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:80175-0472-990 in 1 BOTTLE; Type 0: Not a Combination Product09/24/2018
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA20877409/24/2018
    Labeler - Central Packaging (117617671)
    Establishment
    NameAddressID/FEIBusiness Operations
    Central Packaging, LLC117617671repack(80175-0472)